ADC Therapeutics SA Statistics
NYSE: ADCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.42+0.15 (+11.81%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ADC Therapeutics SA by the numbers
ADC Therapeutics SA has a market capitalization of $181.3 million based on 127.67M shares outstanding. With trailing EPS of $-0.60, ADC Therapeutics SA is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% above its 50-day average and 46.7% below its 200-day average.
Average daily trading volume is 1.34M shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADCT valuation vs. peer median
| Metric | ADCT | Peer median | Difference |
|---|---|---|---|
| Market cap | $181.29M | $180.93M | +0% |
| Avg. volume | 1.34M | 256.79K | +423% |
Peer median across 8 companies: ORMP, CNTN, ANTX, NGEN, YARW, ADAG, ORGO, VRXA.
Valuation
- Market cap
- $181.29M
- EPS (TTM)
- $-0.60
- Shares outstanding
- 127.67M
Price and trading
- Previous close
- 1.27
- Open
- 1.25
- Day range
- 1.24 – 1.44
- 52-week range
- 0.78 – 4.98
- 52-week change
- -67.05%
- Beta
- —
- Volume
- 1.74M
- Average volume
- 1.34M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 181.29M
- Forward Pe
- -0.95
- Eps
- -0.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.98
- Week52 Low
- 0.78
- Avg Volume
- 1.34M
- Shares Outstanding
- 127.67M
- Ma50
- 1.14
- Ma200
- 2.67
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -71.49%
- Pct From52w Low
- 82.05%